Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 301

1.

Euthanasia and physician-assisted suicide in amyotrophic lateral sclerosis: a prospective study.

Maessen M, Veldink JH, Onwuteaka-Philipsen BD, Hendricks HT, Schelhaas HJ, Grupstra HF, van der Wal G, van den Berg LH.

J Neurol. 2014 Jul 15. [Epub ahead of print]

PMID:
25022937
[PubMed - as supplied by publisher]
2.

C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: A genome-wide meta-analysis.

Diekstra FP, Van Deerlin VM, van Swieten JC, Al-Chalabi A, Ludolph AC, Weishaupt JH, Hardiman O, Landers JE, Brown RH Jr, van Es MA, Pasterkamp RJ, Koppers M, Andersen PM, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, van Damme P, Melki J, Meininger V, Shatunov A, Shaw CE, Leigh PN, Shaw PJ, Morrison KE, Fogh I, Chiò A, Traynor BJ, Czell D, Weber M, Heutink P, de Bakker PI, Silani V, Robberecht W, van den Berg LH, Veldink JH.

Ann Neurol. 2014 Jun 16. doi: 10.1002/ana.24198. [Epub ahead of print]

PMID:
24931836
[PubMed - as supplied by publisher]
3.

The provision of assistive devices and home adaptations to patients with ALS in the Netherlands: Patients' perspectives.

Creemers H, Beelen A, Grupstra H, Nollet F, van den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun 5:1-6. [Epub ahead of print]

PMID:
24899120
[PubMed - as supplied by publisher]
4.

Serum angiogenin levels are elevated in ALS, but not Parkinson's disease.

van Es MA, Veldink JH, Schelhaas HJ, Bloem BR, Sodaar P, van Nuenen BF, Verbeek M, van de Warrenburg BP, van den Berg LH.

J Neurol Neurosurg Psychiatry. 2014 May 29. pii: jnnp-2013-307168. doi: 10.1136/jnnp-2013-307168. [Epub ahead of print] No abstract available.

PMID:
24876190
[PubMed - as supplied by publisher]
5.

Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study.

van Doormaal PT, Ticozzi N, Gellera C, Ratti A, Taroni F, Chiò A, Calvo A, Mora G, Restagno G, Traynor BJ, Birve A, Lemmens R, van Es MA, Saris CG, Blauw HM, van Vught PW, Groen EJ, Corrado L, Mazzini L, Del Bo R, Corti S, Waibel S, Meyer T, Ludolph AC, Goris A, van Damme P, Robberecht W, Shatunov A, Fogh I, Andersen PM, D'Alfonso S, Hardiman O, Cronin S, Rujescu D, Al-Chalabi A, Landers JE, Silani V, van den Berg LH, Veldink JH.

Neurobiol Aging. 2014 Oct;35(10):2420.e13-4. doi: 10.1016/j.neurobiolaging.2014.04.014. Epub 2014 Apr 19.

PMID:
24838185
[PubMed - in process]
6.

Chronic idiopathic axonal polyneuropathy and vitamin B6: a controlled population-based study.

Visser NA, Notermans NC, Degen LA, de Kruijk JR, van den Berg LH, Vrancken AF.

J Peripher Nerv Syst. 2014 May 10. doi: 10.1111/jns5.12063. [Epub ahead of print]

PMID:
24813907
[PubMed - as supplied by publisher]
7.

MMN: from immunological cross-talk to conduction block.

Harschnitz O, Jongbloed BA, Franssen H, Straver DC, van der Pol WL, van den Berg LH.

J Clin Immunol. 2014 Jul;34 Suppl 1:S112-9. doi: 10.1007/s10875-014-0026-3. Epub 2014 Apr 13.

PMID:
24728842
[PubMed - in process]
Free PMC Article
8.

A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.

Akimoto C, Volk AE, van Blitterswijk M, Van den Broeck M, Leblond CS, Lumbroso S, Camu W, Neitzel B, Onodera O, van Rheenen W, Pinto S, Weber M, Smith B, Proven M, Talbot K, Keagle P, Chesi A, Ratti A, van der Zee J, Alstermark H, Birve A, Calini D, Nordin A, Tradowsky DC, Just W, Daoud H, Angerbauer S, DeJesus-Hernandez M, Konno T, Lloyd-Jani A, de Carvalho M, Mouzat K, Landers JE, Veldink JH, Silani V, Gitler AD, Shaw CE, Rouleau GA, van den Berg LH, Van Broeckhoven C, Rademakers R, Andersen PM, Kubisch C.

J Med Genet. 2014 Jun;51(6):419-24. doi: 10.1136/jmedgenet-2014-102360. Epub 2014 Apr 4.

PMID:
24706941
[PubMed - in process]
Free PMC Article
9.

No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.

Seelen M, Visser AE, Overste DJ, Kim HJ, Palud A, Wong TH, van Swieten JC, Scheltens P, Voermans NC, Baas F, de Jong JM, van der Kooi AJ, de Visser M, Veldink JH, Taylor JP, Van Es MA, van den Berg LH.

Neurobiol Aging. 2014 Aug;35(8):1956.e9-1956.e11. doi: 10.1016/j.neurobiolaging.2014.01.152. Epub 2014 Feb 6.

PMID:
24612671
[PubMed - in process]
10.

Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis.

Schmidt R, Verstraete E, de Reus MA, Veldink JH, van den Berg LH, van den Heuvel MP.

Hum Brain Mapp. 2014 Sep;35(9):4386-95. doi: 10.1002/hbm.22481. Epub 2014 Mar 6.

PMID:
24604691
[PubMed - in process]
11.

Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathy.

Stork AC, Jacobs BC, Tio-Gillen AP, Eurelings M, Jansen MD, van den Berg LH, Notermans NC, van der Pol WL.

J Neuroimmunol. 2014 Mar 15;268(1-2):89-94. doi: 10.1016/j.jneuroim.2014.01.012. Epub 2014 Jan 29.

PMID:
24529728
[PubMed - indexed for MEDLINE]
12.

Fcγ receptor IIIA genotype is associated with rituximab response in antimyelin-associated glycoprotein neuropathy.

Stork AC, Notermans NC, van den Berg LH, Schellevis RD, Niermeijer JM, Nederend M, Leusen JH, van der Pol WL.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):918-20. doi: 10.1136/jnnp-2013-306958. Epub 2014 Jan 31.

PMID:
24487381
[PubMed - in process]
13.

Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy.

Vlam L, Cats EA, Willemse E, Franssen H, Medic J, Piepers S, Veldink JH, van den Berg LH, van der Pol WL.

J Neurol Neurosurg Psychiatry. 2013 Dec 11. doi: 10.1136/jnnp-2013-306227. [Epub ahead of print]

PMID:
24336791
[PubMed - as supplied by publisher]
14.

Multimodal tract-based analysis in ALS patients at 7T: a specific white matter profile?

Verstraete E, Polders DL, Mandl RC, Van Den Heuvel MP, Veldink JH, Luijten P, Van Den Berg LH, Hoogduin J.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):84-92. doi: 10.3109/21678421.2013.844168. Epub 2013 Dec 10.

PMID:
24325276
[PubMed - in process]
15.

Cluster RCT of case management on patients' quality of life and caregiver strain in ALS.

Creemers H, Veldink JH, Grupstra H, Nollet F, Beelen A, van den Berg LH.

Neurology. 2014 Jan 7;82(1):23-31. doi: 10.1212/01.wnl.0000438227.48470.62. Epub 2013 Nov 27.

PMID:
24285618
[PubMed - indexed for MEDLINE]
16.

A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.

Fogh I, Ratti A, Gellera C, Lin K, Tiloca C, Moskvina V, Corrado L, Sorarù G, Cereda C, Corti S, Gentilini D, Calini D, Castellotti B, Mazzini L, Querin G, Gagliardi S, Del Bo R, Conforti FL, Siciliano G, Inghilleri M, Saccà F, Bongioanni P, Penco S, Corbo M, Sorbi S, Filosto M, Ferlini A, Di Blasio AM, Signorini S, Shatunov A, Jones A, Shaw PJ, Morrison KE, Farmer AE, Van Damme P, Robberecht W, Chiò A, Traynor BJ, Sendtner M, Melki J, Meininger V, Hardiman O, Andersen PM, Leigh NP, Glass JD, Overste D, Diekstra FP, Veldink JH, van Es MA, Shaw CE, Weale ME, Lewis CM, Williams J, Brown RH, Landers JE, Ticozzi N, Ceroni M, Pegoraro E, Comi GP, D'Alfonso S, van den Berg LH, Taroni F, Al-Chalabi A, Powell J, Silani V; SLAGEN Consortium and Collaborators; ITALSGEN Consortium.

Hum Mol Genet. 2014 Apr 15;23(8):2220-31. doi: 10.1093/hmg/ddt587. Epub 2013 Nov 20.

PMID:
24256812
[PubMed - in process]
17.

Clinical variability and additional mutations in amyotrophic lateral sclerosis patients with p.N352S mutations in TARDBP.

van Blitterswijk M, Rademakers R, van den Berg LH.

Neuropathol Appl Neurobiol. 2014 Apr;40(3):356-8. doi: 10.1111/nan.12099. No abstract available.

PMID:
24237396
[PubMed - in process]
18.

No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.

Goris A, van Setten J, Diekstra F, Ripke S, Patsopoulos NA, Sawcer SJ; International Multiple Sclerosis Genetics Consortium, van Es M; Australia and New Zealand MS Genetics Consortium, Andersen PM, Melki J, Meininger V, Hardiman O, Landers JE, Brown RH Jr, Shatunov A, Leigh N, Al-Chalabi A, Shaw CE, Traynor BJ, Chiò A, Restagno G, Mora G, Ophoff RA, Oksenberg JR, Van Damme P, Compston A, Robberecht W, Dubois B, van den Berg LH, De Jager PL, Veldink JH, de Bakker PI.

Hum Mol Genet. 2014 Apr 1;23(7):1916-22. doi: 10.1093/hmg/ddt574. Epub 2013 Nov 13.

PMID:
24234648
[PubMed - in process]
19.

Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?

van den Heuvel DM, Harschnitz O, van den Berg LH, Pasterkamp RJ.

Trends Mol Med. 2014 Jan;20(1):25-35. doi: 10.1016/j.molmed.2013.09.001. Epub 2013 Oct 16.

PMID:
24140266
[PubMed - in process]
20.

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.

Cudkowicz ME, van den Berg LH, Shefner JM, Mitsumoto H, Mora JS, Ludolph A, Hardiman O, Bozik ME, Ingersoll EW, Archibald D, Meyers AL, Dong Y, Farwell WR, Kerr DA; EMPOWER investigators.

Lancet Neurol. 2013 Nov;12(11):1059-67. doi: 10.1016/S1474-4422(13)70221-7. Epub 2013 Sep 23. Erratum in: Lancet Neurol. 2013 Nov;12(11):1042. Carbonell, J G [corrected to Gamez, J].

PMID:
24067398
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk